Small Molecules
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
130
NCT04688580
Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers
Phase: Early Phase 1
Role: Lead Sponsor
Start: Nov 29, 2020
Completion: Dec 14, 2021
NCT04966832
Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults
Phase: Phase 1
Start: Jul 13, 2021
Completion: Jun 13, 2022
NCT05056194
Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study
Phase: Phase 2
Start: Nov 1, 2021
Completion: Nov 1, 2022
Loading map...